C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) G01N 33/53 (2006.01)
Patent
CA 2704497
This invention relates to methods of reducing risk of developing cardiovascular complications in diabetic patients. Specifically, the invention relates to the use of haptoglobin genotyping for determining the importance of maintaining tight glycemic control in diabetic subjects expressing Hp 2-2 allele.
La présente invention concerne des procédés de réduction du risque de développement de complications cardiovasculaires chez les patients diabétiques. Spécifiquement, l'invention concerne l'utilisation du génotypage de l'haptoglobine pour déterminer l'importance du maintien d'un contrôle strict de la glycémie chez des sujets diabétiques exprimant l'allèle Hp 2-2.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Rappaport Family Institute For Research In The Medical Sciences
LandOfFree
Glycemic control for reduction of cardiovascular disease... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glycemic control for reduction of cardiovascular disease..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycemic control for reduction of cardiovascular disease... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1893779